Dr. Antonio Calles ๐ซ๐ญ
@tony_calles
Medical Oncology ๐ฅ Hospital General Universitario Gregorio Maraรฑรณn & @RuberInter โช@myESMO Faculty ๐ซ โช#endlungcancer #lcsm
ID: 2155543177
http://www.linkedin.com/in/antonio-calles-001 25-10-2013 19:57:31
23,23K Tweet
11,11K Followers
4,4K Following
Amivantamab is not an easy drug as highlighted by Dr. Wolf, so the benefit has to outweigh the toxicity. #ESMO24 #LCSM How to incorporate patient-centered decisions in daily practice with the increasingly growing number of choices 4 patients with EGFRmutant NSCLC? EGFR Resisters
